Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCT800 for Prophylaxis in Previously Untreated Severe Hemophilia A
NCT07437404Phase 3Recruiting
- Sponsor
- Sinocelltech Group Limited
- Start
- Apr 2024
- Primary completion
- Dec 2028
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 3 trial of omfiloctocog alfa in hemophilia A, sponsored by Sinocelltech Group Limited. Started Apr 2024; status: recruiting.
02
Drugs
omfiloctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT07437404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07437404.